Treatment patterns of Central Nervous System Tumors in the Veneto Region, Italy: A Population-Based Registry Study (2016-2020)

Authors:

Abstract
Purpose This study provides the first population-based overview of therapeutic approaches for adult CNS tumors in Italy using integrated cancer registry and administrative healthcare data. Methods All adult CNS tumors diagnosed between 2016 and 2020 were identified in the Veneto Cancer Registry. Tumor grade was extracted using a validated text-mining algorithm, and surgical and oncologic treatments were retrieved from administrative datasets and analyzed by histology, grade, and diagnostic approach. Results A total of 1,634 histologically confirmed CNS tumors were included. Glioblastoma was the most frequent subtype (64.6%), followed by grade 2–3 meningiomas (18.2%). Most glioblastomas (80%) and all meningiomas underwent resection, whereas biopsies were more common in grade 2–3 astrocytomas (23–30%) and oligodendrogliomas (10–11%). Adjuvant chemoradiotherapy was the predominant treatment in glioblastoma (60.2%), grade 3 astrocytoma (65.2%) and oligodendroglioma (58%). In recurrent grade 4 astrocytomas, nitrosoureas and regorafenib were the most frequently used therapies. Among low-grade tumors, 68.9% of astrocytomas and 63.9% of oligodendrogliomas received radiotherapy, chemotherapy, or both as adjuvant therapy. Non-biopsied patients rarely received active treatment and had poor survival, with better 1-year survival observed in those who received chemotherapy or radiotherapy alone. Conclusions This population-based study outlines real-world CNS tumor management in the Veneto Region, showing that most patients undergo surgery and that oncologic strategies vary by tumor type and grade. Integrating registry and administrative data allows effective monitoring of treatment patterns and supports improvements in multidisciplinary care and access.

This publication has 13 references indexed in Scilit: